Symyx Technologies, Inc. launched its new client-directed and collaborative research services for Life Sciences. These services allow clients to access Symyx’s installed base of parallel experimentation and testing capabilities through packaged offerings for solubility studies, polymorph screening, salt selection, co-crystallization, API stability in liquid and solid formulations, excipient compatibility, organic synthesis and process optimization.
    
Symyx recently signed a one-year agreement with Bristol-Myers Squibb for the use of Symyx Research Services for solubility studies. Under terms of the agreement, Symyx will perform solubility studies for BMS through May 2009.
    
“Symyx Research is continuing to transform its offerings into packaged, smaller scope and easily accessible solutions,” said Richard Boehner, president of Symyx Research. “We are pleased to enter this agreement with Bristol-Myers Squibb to provide solubility research services which will help them achieve a greater level of R&D efficiency.”